miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1

Jinhui Wang(Sun Yat-sen University), Qinggang Meng(Beijing University of Chinese Medicine)
OncoTargets and Therapy
February 1, 2017
Cited by 22


Related Papers